查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1225046

職業篩選市場：按類型、技術、最終用戶分類：全球機會分析和行業預測，2021-2031 年

Carrier Screening Market By Type, By Technology, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 | 商品交期: 2-3個工作天內

價格

2021 年全球職業篩選市場價值 18.4936 億美元，到 2031 年將達到 64.546 億美元，2022-2031 年的複合年增長率預計為 13.8%

進行基因檢測是為了查看您在出現症狀之前是否在您的家族史中有遺傳病或疾病，或者您是否可以將遺傳病遺傳給您的孩子。. 遺傳諮詢師幫助人們決定應該進行哪些測試並理解這些測試。 孕婦通過羊膜穿刺術檢測羊水，通過絨毛膜絨毛取樣檢測胎盤。 它也可以在體外受精 (IVF) 期間對胚胎進行。 通常需要數週時間才能獲得測試結果。 適合進行基因檢測的疾病包括囊性纖維化、泰-薩克斯病、鐮狀細胞病、唐氏症、脊柱裂、特納症候群、血管性血友病、白化病和杜氏肌營養不良症。

遺傳疾病發病率上升、市場上先進產品數量增加以及測試可用性和價格上漲是推動市場增長的因素。 越來越多的生物技術公司採用收購等戰略，預計也將對市場增長做出重大貢獻。 例如，2021 年 8 月，DiaSorin S.p.A. 宣布以每股 37 美元的價格完成對 Luminex Corporation 的收購，股權價值約為 18 億美元。 此次收購將使 DiaSorin 獲得 Luminex 的多路復用技術和產品組合，增強其現有產品並擴大集團在美國的業務。 此外，全球攜帶者篩查市場的增長受到遺傳疾病領域對攜帶者篩查的偏好增加、政府和私人組織對大規模攜帶者篩查項目的各種舉措和資助以及篩查成本下降等因素的推動。影響很大。 全球職業篩選市場的主要市場參與者正在選擇各種戰略，例如投資於職業篩選進步的研發，以加強其市場地位並保持競爭格局。增加。 然而，與職業篩選相關的高成本和熟練專業人員的短缺限制了市場增長。 相反，各種技術進步，例如用於遺傳疾病篩查和 DNA 測序的下一代測序 (NGS) 技術的開發，有望在未來幾年為市場增長提供有利可圖的機會。 生物信息學和生物技術領域研發活動的增加，以及醫療基礎設施的顯著改善，預計將增加市場機會。

內容

第 1 章介紹

第 2 章執行摘要

第 3 章市場概述

  • 市場定義和範圍
  • 主要發現
    • 主要投資領域
  • 波特的五力分析
  • 市場動態
    • 促進因素
      • 遺傳性疾病增加
      • 不斷進步的技術進步
      • 提高對疾病早期診斷的認識
    • 抑制因素
      • 與職業篩選相關的高成本和熟練專業人員短缺
    • 機會
      • 研發投資增加：按製藥公司分類
  • 分析 COVID-19 對市場的影響

第 4 章職業篩選市場：按類型

  • 概覽
    • 市場規模和預測
  • 擴展攜帶者篩查
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 目標疾病攜帶者篩查
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 5 章職業篩選市場：按技術分類

  • 概覽
    • 市場規模和預測
  • DNA測序
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 聚合□鏈反應
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 微陣列
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 其他
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 6 章職業篩選市場：按最終用戶分類

  • 概覽
    • 市場規模和預測
  • 醫院和診所
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 參考實驗室
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 醫務室
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 其他
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 7 章職業篩選市場：按地區

  • 概覽
    • 市場規模和預測
  • 北美
    • 主要趨勢和機會
    • 北美市場規模和預測：按類型
    • 北美市場規模和預測：按技術分類
    • 北美市場規模和預測：按最終用戶分類
    • 北美市場規模和預測：按國家/地區分類
      • 美國
      • 主要市場趨勢、增長因素和機遇
      • 市場規模/預測：按類型
      • 市場規模/預測：按技術分類
      • 市場規模和預測：按最終用戶分類
      • 加拿大
      • 主要市場趨勢、增長因素和機遇
      • 市場規模/預測：按類型
      • 市場規模/預測：按技術分類
      • 市場規模和預測：按最終用戶分類
      • 墨西哥
      • 主要市場趨勢、增長因素和機遇
      • 市場規模/預測：按類型
      • 市場規模/預測：按技術分類
      • 市場規模和預測：按最終用戶分類
  • 歐洲
    • 主要趨勢和機會
    • 歐洲市場規模和預測：按類型
    • 歐洲市場規模和預測：按技術分類
    • 歐洲市場規模和預測：按最終用戶分類
    • 歐洲市場規模和預測：按國家/地區分類
      • 德國
      • 主要市場趨勢、增長因素和機遇
      • 德國市場規模和預測：按類型
      • 市場規模/預測：按技術分類
      • 市場規模和預測：按最終用戶分類
      • 法國
      • 主要市場趨勢、增長因素和機遇
      • 市場規模/預測：按類型
      • 市場規模/預測：按技術分類
      • 市場規模和預測：按最終用戶分類
      • 英國
      • 主要市場趨勢、增長因素和機遇
      • 市場規模/預測：按類型
      • 市場規模/預測：按技術分類
      • 市場規模和預測：按最終用戶分類
      • 意大利
      • 主要市場趨勢、增長因素和機遇
      • 市場規模/預測：按類型
      • 市場規模/預測：按技術分類
      • 市場規模和預測：按最終用戶分類
      • 西班牙
      • 主要市場趨勢、增長因素和機遇
      • 市場規模/預測：按類型
      • 市場規模/預測：按技術分類
      • 市場規模和預測：按最終用戶分類
      • 其他歐洲
      • 主要市場趨勢、增長因素和機遇
      • 市場規模/預測：按類型
      • 市場規模/預測：按技術分類
      • 市場規模和預測：按最終用戶分類
  • 亞太地區
    • 主要趨勢和機會
    • 亞太市場規模和預測：按類型
    • 亞太市場規模和預測：按技術分類
    • 亞太市場規模和預測：按最終用戶分類
    • 亞太地區的市場規模和預測：按國家/地區分類
      • 日本
      • 主要市場趨勢、增長因素和機遇
      • 亞太市場規模和預測：按類型
      • 亞太市場規模和預測：按技術分類
      • 市場規模和預測：按最終用戶分類
      • 中國
      • 主要市場趨勢、增長因素和機遇
      • 市場規模/預測：按類型
      • 市場規模/預測：按技術分類
      • 市場規模和預測：按最終用戶分類
      • 澳大利亞
      • 主要市場趨勢、增長因素和機遇
      • 市場規模/預測：按類型
      • 市場規模/預測：按技術分類
      • 市場規模和預測：按最終用戶分類
      • 印度
      • 主要市場趨勢、增長因素和機遇
      • 市場規模/預測：按類型
      • 市場規模/預測：按技術分類
      • 市場規模和預測：按最終用戶分類
      • 韓國
      • 主要市場趨勢、增長因素和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按技術分類
      • 市場規模和預測：按最終用戶分類
      • 其他亞太地區
      • 主要市場趨勢、增長因素和機遇
      • 市場規模/預測：按類型
      • 市場規模/預測：按技術分類
      • 市場規模和預測：按最終用戶分類
  • 拉丁美洲/中東/非洲
    • 主要趨勢和機會
    • LAMEA 市場規模和預測：按類型
    • LAMEA 市場規模和預測：按技術分類
    • LAMEA 市場規模和預測：按最終用戶分類
    • LAMEA 市場規模和預測：按國家/地區分類
      • 巴西
      • 主要市場趨勢、增長因素和機遇
      • 市場規模/預測：按類型
      • 市場規模/預測：按技術分類
      • 市場規模和預測：按最終用戶分類
      • 沙特阿拉伯
      • 主要市場趨勢、增長因素和機遇
      • 市場規模/預測：按類型
      • 市場規模/預測：按技術分類
      • 市場規模和預測：按最終用戶分類
      • 南非
      • 主要市場趨勢、增長因素和機遇
      • 市場規模/預測：按類型
      • 市場規模/預測：按技術分類
      • 市場規模和預測：按最終用戶分類
      • LAMEA 的其餘部分
      • 主要市場趨勢、增長因素和機遇
      • 市場規模/預測：按類型
      • 市場規模/預測：按技術分類
      • 市場規模和預測：按最終用戶分類

第 8 章競爭格局

  • 介紹
  • 關鍵成功策略
  • 排名前 10 位的玩家產品映射
  • 比賽儀表板
  • 競爭熱圖
  • 定位頂級公司，2021 年

第 9 章公司簡介

  • Fulgent Genetics Inc.
  • Illumina Inc.
  • Diasorin S.p.A.
  • Natera Inc.
  • Thermo Fisher Scientific Inc.
  • Eurofins Scientific
  • Myriad Genetics, Inc.
  • Opko Health Inc
  • Quest Diagnostics Inc.
  • InVitae Corporation
Product Code: A11271

The global carrier screening market was valued at $1,849.36 million in 2021 and is projected to reach $6,454.60 million by 2031, registering a CAGR of 13.8% from 2022 to 2031. Genetic testing is done for checking if people have genetic conditions or diseases that may be present in the family history prior to the occurrence of the symptoms or if people can pass on that genetic condition to their children. Genetic counselors help people decide what tests to get and understand the meaning of tests. It can be done on amniotic fluid through amniocentesis or the placenta through chorionic villus sampling in pregnant women. It can also be done on an embryo during in vitro fertilization (IVF). Usually, it takes a few weeks for test results to be ready. Some of the diseases for which genetic testing is preferred include cystic fibrosis, Tay-Sachs disease, sickle cell disease, down syndrome, spina bifida, turner syndrome, von Willebrand disease, albinism, and Duchenne muscular dystrophy.

An increase in the incidence of genetic diseases, a rise in the number of advanced product launches, and a surge in the availability & affordability of tests are the factors responsible for driving the growth of the market. Moreover, an increase in the number of biotechnology companies adopting strategies like acquisition is expected to notably contribute toward market growth. For instance, in August 2021, DiaSorin S.p.A. announced that it has completed the acquisition of Luminex Corporation for a price of $37.00 per share which corresponds to a total equity value of approximately $1.8 billion. Through the acquisition, DiaSorin has gained access to Luminex's multiplexing technology and a portfolio that will strengthen its existing offering, while expanding the Group presence in the U.S. In addition, the global carrier screening market growth is largely driven by factors such as an increase in preference of carrier screening in genetic disorder fields, various initiatives & funding from government & private bodies for large-scale carrier screening projects and decline in cost of screening. The key market players in the global carrier screening market have opted for various strategies such as investments in R&D for advancement in carrier screening to strengthen their position in the market and sustain the competitive environment. However, the high cost associated with carrier screening and the dearth of skilled professionals restricts the market growth. Conversely, various technological advancements such as the development of next-generation sequencing (NGS) techniques for genetic disease screening and DNA sequencing are expected to provide lucrative opportunities for the growth of the market in the coming years. The increase in the R&D activities in the field of bioinformatics and biotechnology along with significant improvement in medical infrastructure is anticipated to increase the opportunities of the market.

The carrier screening market is segmented based on type, technology, end-user, and region. On the basis of type, the market is bifurcated into expanded carrier screening and targeted disease carrier screening. On the basis of technology, the market is classified into DNA sequencing, polymerase chain reaction, microarrays, and others. On the basis of end users, the market is classified into hospitals & clinics, reference laboratories, physician offices, and others. Region-wise, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and the Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major companies profiled in the report include Diasorin S.p.A (Luminex Corporation), Eurofins Scientific, Fulgent Genetics Inc., Illumina Inc., Invitae Corporation, Myriad Genetics Inc., Natera Inc., Opko Health Inc., Quest Diagnostics Incorporated, Thermo Fisher Scientific Inc.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the carrier screening market analysis from 2021 to 2031 to identify the prevailing carrier screening market opportunities.

Market research is offered along with information related to key drivers, restraints, and opportunities.

Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.

An in-depth analysis of the carrier screening market segmentation assists to determine the prevailing market opportunities.

Major countries in each region are mapped according to their revenue contribution to the global market.

Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

The report includes analysis of the regional as well as global carrier screening market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

  • Expanded Carrier Screening
  • Targeted Disease Carrier Screening

By Technology

  • DNA Sequencing
  • Polymerase Chain Reaction
  • Microarrays
  • Others

By End User

  • Hospitals and clinics
  • Reference Laboratories
  • Physician Offices
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • Fulgent Genetics Inc.
    • Illumina Inc.
    • Diasorin S.p.A.
    • Natera Inc.
    • Thermo Fisher Scientific Inc.
    • Eurofins Scientific
    • Myriad Genetics, Inc.
    • Opko Health Inc
    • Quest Diagnostics Inc.
    • InVitae Corporation

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Market dynamics
    • 3.4.1.Drivers
      • 3.4.1.1. Increase in the prevalence of genetic disorders
      • 3.4.1.2. Rise in the technological advancements
      • 3.4.1.3. Rise in awareness for early disease diagnosis
    • 3.4.2.Restraints
      • 3.4.2.1. High cost associated with carrier screening and dearth of skilled professionals
    • 3.4.3.Opportunities
      • 3.4.3.1. Rise in the number of R&D investment by pharmaceutical companies
  • 3.5.COVID-19 Impact Analysis on the market

CHAPTER 4: CARRIER SCREENING MARKET, BY TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2. Expanded Carrier Screening
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market share analysis by country
  • 4.3. Targeted Disease Carrier Screening
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market share analysis by country

CHAPTER 5: CARRIER SCREENING MARKET, BY TECHNOLOGY

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2. DNA Sequencing
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market share analysis by country
  • 5.3. Polymerase Chain Reaction
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market share analysis by country
  • 5.4. Microarrays
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market share analysis by country
  • 5.5. Others
    • 5.5.1 Key market trends, growth factors and opportunities
    • 5.5.2 Market size and forecast, by region
    • 5.5.3 Market share analysis by country

CHAPTER 6: CARRIER SCREENING MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2. Hospitals and clinics
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market share analysis by country
  • 6.3. Reference Laboratories
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market share analysis by country
  • 6.4. Physician Offices
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market share analysis by country
  • 6.5. Others
    • 6.5.1 Key market trends, growth factors and opportunities
    • 6.5.2 Market size and forecast, by region
    • 6.5.3 Market share analysis by country

CHAPTER 7: CARRIER SCREENING MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Type
    • 7.2.3 North America Market size and forecast, by Technology
    • 7.2.4 North America Market size and forecast, by End User
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Key market trends, growth factors and opportunities
      • 7.2.5.1.2 Market size and forecast, by Type
      • 7.2.5.1.3 Market size and forecast, by Technology
      • 7.2.5.1.4 Market size and forecast, by End User
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Key market trends, growth factors and opportunities
      • 7.2.5.2.2 Market size and forecast, by Type
      • 7.2.5.2.3 Market size and forecast, by Technology
      • 7.2.5.2.4 Market size and forecast, by End User
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Key market trends, growth factors and opportunities
      • 7.2.5.3.2 Market size and forecast, by Type
      • 7.2.5.3.3 Market size and forecast, by Technology
      • 7.2.5.3.4 Market size and forecast, by End User
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Type
    • 7.3.3 Europe Market size and forecast, by Technology
    • 7.3.4 Europe Market size and forecast, by End User
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Key market trends, growth factors and opportunities
      • 7.3.5.1.2 Market size and forecast, by Type
      • 7.3.5.1.3 Market size and forecast, by Technology
      • 7.3.5.1.4 Market size and forecast, by End User
      • 7.3.5.2 France
      • 7.3.5.2.1 Key market trends, growth factors and opportunities
      • 7.3.5.2.2 Market size and forecast, by Type
      • 7.3.5.2.3 Market size and forecast, by Technology
      • 7.3.5.2.4 Market size and forecast, by End User
      • 7.3.5.3 UK
      • 7.3.5.3.1 Key market trends, growth factors and opportunities
      • 7.3.5.3.2 Market size and forecast, by Type
      • 7.3.5.3.3 Market size and forecast, by Technology
      • 7.3.5.3.4 Market size and forecast, by End User
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Key market trends, growth factors and opportunities
      • 7.3.5.4.2 Market size and forecast, by Type
      • 7.3.5.4.3 Market size and forecast, by Technology
      • 7.3.5.4.4 Market size and forecast, by End User
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Key market trends, growth factors and opportunities
      • 7.3.5.5.2 Market size and forecast, by Type
      • 7.3.5.5.3 Market size and forecast, by Technology
      • 7.3.5.5.4 Market size and forecast, by End User
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Key market trends, growth factors and opportunities
      • 7.3.5.6.2 Market size and forecast, by Type
      • 7.3.5.6.3 Market size and forecast, by Technology
      • 7.3.5.6.4 Market size and forecast, by End User
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Type
    • 7.4.3 Asia-Pacific Market size and forecast, by Technology
    • 7.4.4 Asia-Pacific Market size and forecast, by End User
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 Japan
      • 7.4.5.1.1 Key market trends, growth factors and opportunities
      • 7.4.5.1.2 Market size and forecast, by Type
      • 7.4.5.1.3 Market size and forecast, by Technology
      • 7.4.5.1.4 Market size and forecast, by End User
      • 7.4.5.2 China
      • 7.4.5.2.1 Key market trends, growth factors and opportunities
      • 7.4.5.2.2 Market size and forecast, by Type
      • 7.4.5.2.3 Market size and forecast, by Technology
      • 7.4.5.2.4 Market size and forecast, by End User
      • 7.4.5.3 Australia
      • 7.4.5.3.1 Key market trends, growth factors and opportunities
      • 7.4.5.3.2 Market size and forecast, by Type
      • 7.4.5.3.3 Market size and forecast, by Technology
      • 7.4.5.3.4 Market size and forecast, by End User
      • 7.4.5.4 India
      • 7.4.5.4.1 Key market trends, growth factors and opportunities
      • 7.4.5.4.2 Market size and forecast, by Type
      • 7.4.5.4.3 Market size and forecast, by Technology
      • 7.4.5.4.4 Market size and forecast, by End User
      • 7.4.5.5 South Korea
      • 7.4.5.5.1 Key market trends, growth factors and opportunities
      • 7.4.5.5.2 Market size and forecast, by Type
      • 7.4.5.5.3 Market size and forecast, by Technology
      • 7.4.5.5.4 Market size and forecast, by End User
      • 7.4.5.6 Rest of Asia-Pacific
      • 7.4.5.6.1 Key market trends, growth factors and opportunities
      • 7.4.5.6.2 Market size and forecast, by Type
      • 7.4.5.6.3 Market size and forecast, by Technology
      • 7.4.5.6.4 Market size and forecast, by End User
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Type
    • 7.5.3 LAMEA Market size and forecast, by Technology
    • 7.5.4 LAMEA Market size and forecast, by End User
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Key market trends, growth factors and opportunities
      • 7.5.5.1.2 Market size and forecast, by Type
      • 7.5.5.1.3 Market size and forecast, by Technology
      • 7.5.5.1.4 Market size and forecast, by End User
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Key market trends, growth factors and opportunities
      • 7.5.5.2.2 Market size and forecast, by Type
      • 7.5.5.2.3 Market size and forecast, by Technology
      • 7.5.5.2.4 Market size and forecast, by End User
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Key market trends, growth factors and opportunities
      • 7.5.5.3.2 Market size and forecast, by Type
      • 7.5.5.3.3 Market size and forecast, by Technology
      • 7.5.5.3.4 Market size and forecast, by End User
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Key market trends, growth factors and opportunities
      • 7.5.5.4.2 Market size and forecast, by Type
      • 7.5.5.4.3 Market size and forecast, by Technology
      • 7.5.5.4.4 Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top player positioning, 2021

CHAPTER 9: COMPANY PROFILES

  • 9.1 Fulgent Genetics Inc.
    • 9.1.1 Company overview
    • 9.1.2 Key Executives
    • 9.1.3 Company snapshot
    • 9.1.4 Operating business segments
    • 9.1.5 Product portfolio
    • 9.1.6 Business performance
    • 9.1.7 Key strategic moves and developments
  • 9.2 Illumina Inc.
    • 9.2.1 Company overview
    • 9.2.2 Key Executives
    • 9.2.3 Company snapshot
    • 9.2.4 Operating business segments
    • 9.2.5 Product portfolio
    • 9.2.6 Business performance
    • 9.2.7 Key strategic moves and developments
  • 9.3 Diasorin S.p.A.
    • 9.3.1 Company overview
    • 9.3.2 Key Executives
    • 9.3.3 Company snapshot
    • 9.3.4 Operating business segments
    • 9.3.5 Product portfolio
    • 9.3.6 Business performance
    • 9.3.7 Key strategic moves and developments
  • 9.4 Natera Inc.
    • 9.4.1 Company overview
    • 9.4.2 Key Executives
    • 9.4.3 Company snapshot
    • 9.4.4 Operating business segments
    • 9.4.5 Product portfolio
    • 9.4.6 Business performance
    • 9.4.7 Key strategic moves and developments
  • 9.5 Thermo Fisher Scientific Inc.
    • 9.5.1 Company overview
    • 9.5.2 Key Executives
    • 9.5.3 Company snapshot
    • 9.5.4 Operating business segments
    • 9.5.5 Product portfolio
    • 9.5.6 Business performance
    • 9.5.7 Key strategic moves and developments
  • 9.6 Eurofins Scientific
    • 9.6.1 Company overview
    • 9.6.2 Key Executives
    • 9.6.3 Company snapshot
    • 9.6.4 Operating business segments
    • 9.6.5 Product portfolio
    • 9.6.6 Business performance
    • 9.6.7 Key strategic moves and developments
  • 9.7 Myriad Genetics, Inc.
    • 9.7.1 Company overview
    • 9.7.2 Key Executives
    • 9.7.3 Company snapshot
    • 9.7.4 Operating business segments
    • 9.7.5 Product portfolio
    • 9.7.6 Business performance
    • 9.7.7 Key strategic moves and developments
  • 9.8 Opko Health Inc
    • 9.8.1 Company overview
    • 9.8.2 Key Executives
    • 9.8.3 Company snapshot
    • 9.8.4 Operating business segments
    • 9.8.5 Product portfolio
    • 9.8.6 Business performance
    • 9.8.7 Key strategic moves and developments
  • 9.9 Quest Diagnostics Inc.
    • 9.9.1 Company overview
    • 9.9.2 Key Executives
    • 9.9.3 Company snapshot
    • 9.9.4 Operating business segments
    • 9.9.5 Product portfolio
    • 9.9.6 Business performance
    • 9.9.7 Key strategic moves and developments
  • 9.10 InVitae Corporation
    • 9.10.1 Company overview
    • 9.10.2 Key Executives
    • 9.10.3 Company snapshot
    • 9.10.4 Operating business segments
    • 9.10.5 Product portfolio
    • 9.10.6 Business performance
    • 9.10.7 Key strategic moves and developments

LIST OF TABLES

  • TABLE 1. GLOBAL CARRIER SCREENING MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 2. CARRIER SCREENING MARKET FOR EXPANDED CARRIER SCREENING, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 3. CARRIER SCREENING MARKET FOR TARGETED DISEASE CARRIER SCREENING, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 4. GLOBAL CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 5. CARRIER SCREENING MARKET FOR DNA SEQUENCING, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 6. CARRIER SCREENING MARKET FOR POLYMERASE CHAIN REACTION, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 7. CARRIER SCREENING MARKET FOR MICROARRAYS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 8. CARRIER SCREENING MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 9. GLOBAL CARRIER SCREENING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 10. CARRIER SCREENING MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 11. CARRIER SCREENING MARKET FOR REFERENCE LABORATORIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 12. CARRIER SCREENING MARKET FOR PHYSICIAN OFFICES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 13. CARRIER SCREENING MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 14. CARRIER SCREENING MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 15. NORTH AMERICA CARRIER SCREENING MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 16. NORTH AMERICA CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 17. NORTH AMERICA CARRIER SCREENING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 18. NORTH AMERICA CARRIER SCREENING MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 19. U.S. CARRIER SCREENING MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 20. U.S. CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 21. U.S. CARRIER SCREENING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 22. CANADA CARRIER SCREENING MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 23. CANADA CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 24. CANADA CARRIER SCREENING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 25. MEXICO CARRIER SCREENING MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 26. MEXICO CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 27. MEXICO CARRIER SCREENING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 28. EUROPE CARRIER SCREENING MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 29. EUROPE CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 30. EUROPE CARRIER SCREENING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 31. EUROPE CARRIER SCREENING MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 32. GERMANY CARRIER SCREENING MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 33. GERMANY CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 34. GERMANY CARRIER SCREENING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 35. FRANCE CARRIER SCREENING MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 36. FRANCE CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 37. FRANCE CARRIER SCREENING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 38. UK CARRIER SCREENING MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 39. UK CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 40. UK CARRIER SCREENING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 41. ITALY CARRIER SCREENING MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 42. ITALY CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 43. ITALY CARRIER SCREENING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 44. SPAIN CARRIER SCREENING MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 45. SPAIN CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 46. SPAIN CARRIER SCREENING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 47. REST OF EUROPE CARRIER SCREENING MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 48. REST OF EUROPE CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 49. REST OF EUROPE CARRIER SCREENING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 50. ASIA-PACIFIC CARRIER SCREENING MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 51. ASIA-PACIFIC CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 52. ASIA-PACIFIC CARRIER SCREENING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 53. ASIA-PACIFIC CARRIER SCREENING MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 54. JAPAN CARRIER SCREENING MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 55. JAPAN CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 56. JAPAN CARRIER SCREENING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 57. CHINA CARRIER SCREENING MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 58. CHINA CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 59. CHINA CARRIER SCREENING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 60. AUSTRALIA CARRIER SCREENING MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 61. AUSTRALIA CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 62. AUSTRALIA CARRIER SCREENING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 63. INDIA CARRIER SCREENING MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 64. INDIA CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 65. INDIA CARRIER SCREENING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 66. SOUTH KOREA CARRIER SCREENING MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 67. SOUTH KOREA CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 68. SOUTH KOREA CARRIER SCREENING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 69. REST OF ASIA-PACIFIC CARRIER SCREENING MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 70. REST OF ASIA-PACIFIC CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 71. REST OF ASIA-PACIFIC CARRIER SCREENING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 72. LAMEA CARRIER SCREENING MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 73. LAMEA CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 74. LAMEA CARRIER SCREENING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 75. LAMEA CARRIER SCREENING MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 76. BRAZIL CARRIER SCREENING MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 77. BRAZIL CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 78. BRAZIL CARRIER SCREENING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 79. SAUDI ARABIA CARRIER SCREENING MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 80. SAUDI ARABIA CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 81. SAUDI ARABIA CARRIER SCREENING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 82. SOUTH AFRICA CARRIER SCREENING MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 83. SOUTH AFRICA CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 84. SOUTH AFRICA CARRIER SCREENING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 85. REST OF LAMEA CARRIER SCREENING MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 86. REST OF LAMEA CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 87. REST OF LAMEA CARRIER SCREENING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 88. FULGENT GENETICS INC.: KEY EXECUTIVES
  • TABLE 89. FULGENT GENETICS INC.: COMPANY SNAPSHOT
  • TABLE 90. FULGENT GENETICS INC.: OPERATING SEGMENTS
  • TABLE 91. FULGENT GENETICS INC.: PRODUCT PORTFOLIO
  • TABLE 92. FULGENT GENETICS INC.: NET SALES
  • TABLE 93. FULGENT GENETICS INC.: KEY STRATERGIES
  • TABLE 94. ILLUMINA INC.: KEY EXECUTIVES
  • TABLE 95. ILLUMINA INC.: COMPANY SNAPSHOT
  • TABLE 96. ILLUMINA INC.: OPERATING SEGMENTS
  • TABLE 97. ILLUMINA INC.: PRODUCT PORTFOLIO
  • TABLE 98. ILLUMINA INC.: NET SALES
  • TABLE 99. ILLUMINA INC.: KEY STRATERGIES
  • TABLE 100. DIASORIN S.P.A.: KEY EXECUTIVES
  • TABLE 101. DIASORIN S.P.A.: COMPANY SNAPSHOT
  • TABLE 102. DIASORIN S.P.A.: OPERATING SEGMENTS
  • TABLE 103. DIASORIN S.P.A.: PRODUCT PORTFOLIO
  • TABLE 104. DIASORIN S.P.A.: NET SALES
  • TABLE 105. DIASORIN S.P.A.: KEY STRATERGIES
  • TABLE 106. NATERA INC.: KEY EXECUTIVES
  • TABLE 107. NATERA INC.: COMPANY SNAPSHOT
  • TABLE 108. NATERA INC.: OPERATING SEGMENTS
  • TABLE 109. NATERA INC.: PRODUCT PORTFOLIO
  • TABLE 110. NATERA INC.: NET SALES
  • TABLE 111. NATERA INC.: KEY STRATERGIES
  • TABLE 112. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES
  • TABLE 113. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • TABLE 114. THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
  • TABLE 115. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
  • TABLE 116. THERMO FISHER SCIENTIFIC INC.: NET SALES
  • TABLE 117. THERMO FISHER SCIENTIFIC INC.: KEY STRATERGIES
  • TABLE 118. EUROFINS SCIENTIFIC: KEY EXECUTIVES
  • TABLE 119. EUROFINS SCIENTIFIC: COMPANY SNAPSHOT
  • TABLE 120. EUROFINS SCIENTIFIC: OPERATING SEGMENTS
  • TABLE 121. EUROFINS SCIENTIFIC: PRODUCT PORTFOLIO
  • TABLE 122. EUROFINS SCIENTIFIC: NET SALES
  • TABLE 123. EUROFINS SCIENTIFIC: KEY STRATERGIES
  • TABLE 124. MYRIAD GENETICS, INC.: KEY EXECUTIVES
  • TABLE 125. MYRIAD GENETICS, INC.: COMPANY SNAPSHOT
  • TABLE 126. MYRIAD GENETICS, INC.: OPERATING SEGMENTS
  • TABLE 127. MYRIAD GENETICS, INC.: PRODUCT PORTFOLIO
  • TABLE 128. MYRIAD GENETICS, INC.: NET SALES
  • TABLE 129. MYRIAD GENETICS, INC.: KEY STRATERGIES
  • TABLE 130. OPKO HEALTH INC: KEY EXECUTIVES
  • TABLE 131. OPKO HEALTH INC: COMPANY SNAPSHOT
  • TABLE 132. OPKO HEALTH INC: OPERATING SEGMENTS
  • TABLE 133. OPKO HEALTH INC: PRODUCT PORTFOLIO
  • TABLE 134. OPKO HEALTH INC: NET SALES
  • TABLE 135. OPKO HEALTH INC: KEY STRATERGIES
  • TABLE 136. QUEST DIAGNOSTICS INC.: KEY EXECUTIVES
  • TABLE 137. QUEST DIAGNOSTICS INC.: COMPANY SNAPSHOT
  • TABLE 138. QUEST DIAGNOSTICS INC.: OPERATING SEGMENTS
  • TABLE 139. QUEST DIAGNOSTICS INC.: PRODUCT PORTFOLIO
  • TABLE 140. QUEST DIAGNOSTICS INC.: NET SALES
  • TABLE 141. QUEST DIAGNOSTICS INC.: KEY STRATERGIES
  • TABLE 142. INVITAE CORPORATION: KEY EXECUTIVES
  • TABLE 143. INVITAE CORPORATION: COMPANY SNAPSHOT
  • TABLE 144. INVITAE CORPORATION: OPERATING SEGMENTS
  • TABLE 145. INVITAE CORPORATION: PRODUCT PORTFOLIO
  • TABLE 146. INVITAE CORPORATION: NET SALES
  • TABLE 147. INVITAE CORPORATION: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1. SEGMENTATION OF CARRIER SCREENING MARKET,2021-2031
  • FIGURE 2. CARRIER SCREENING MARKET,2021-2031
  • FIGURE 3. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 4. PORTER FIVE-1
  • FIGURE 5. PORTER FIVE-2
  • FIGURE 6. PORTER FIVE-3
  • FIGURE 7. PORTER FIVE-4
  • FIGURE 8. PORTER FIVE-5
  • FIGURE 9. CARRIER SCREENING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 10. CARRIER SCREENING MARKET,BY TYPE,2021(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF EXPANDED CARRIER SCREENING CARRIER SCREENING MARKET, 2021 AND 2031(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF TARGETED DISEASE CARRIER SCREENING CARRIER SCREENING MARKET, 2021 AND 2031(%)
  • FIGURE 13. CARRIER SCREENING MARKET,BY TECHNOLOGY,2021(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF DNA SEQUENCING CARRIER SCREENING MARKET, 2021 AND 2031(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF POLYMERASE CHAIN REACTION CARRIER SCREENING MARKET, 2021 AND 2031(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF MICROARRAYS CARRIER SCREENING MARKET, 2021 AND 2031(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF OTHERS CARRIER SCREENING MARKET, 2021 AND 2031(%)
  • FIGURE 18. CARRIER SCREENING MARKET,BY END USER,2021(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF HOSPITALS AND CLINICS CARRIER SCREENING MARKET, 2021 AND 2031(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF REFERENCE LABORATORIES CARRIER SCREENING MARKET, 2021 AND 2031(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF PHYSICIAN OFFICES CARRIER SCREENING MARKET, 2021 AND 2031(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF OTHERS CARRIER SCREENING MARKET, 2021 AND 2031(%)
  • FIGURE 23. CARRIER SCREENING MARKET BY REGION,2021
  • FIGURE 24. U.S. CARRIER SCREENING MARKET,2021-2031($MILLION)
  • FIGURE 25. CANADA CARRIER SCREENING MARKET,2021-2031($MILLION)
  • FIGURE 26. MEXICO CARRIER SCREENING MARKET,2021-2031($MILLION)
  • FIGURE 27. GERMANY CARRIER SCREENING MARKET,2021-2031($MILLION)
  • FIGURE 28. FRANCE CARRIER SCREENING MARKET,2021-2031($MILLION)
  • FIGURE 29. UK CARRIER SCREENING MARKET,2021-2031($MILLION)
  • FIGURE 30. ITALY CARRIER SCREENING MARKET,2021-2031($MILLION)
  • FIGURE 31. SPAIN CARRIER SCREENING MARKET,2021-2031($MILLION)
  • FIGURE 32. REST OF EUROPE CARRIER SCREENING MARKET,2021-2031($MILLION)
  • FIGURE 33. JAPAN CARRIER SCREENING MARKET,2021-2031($MILLION)
  • FIGURE 34. CHINA CARRIER SCREENING MARKET,2021-2031($MILLION)
  • FIGURE 35. AUSTRALIA CARRIER SCREENING MARKET,2021-2031($MILLION)
  • FIGURE 36. INDIA CARRIER SCREENING MARKET,2021-2031($MILLION)
  • FIGURE 37. SOUTH KOREA CARRIER SCREENING MARKET,2021-2031($MILLION)
  • FIGURE 38. REST OF ASIA-PACIFIC CARRIER SCREENING MARKET,2021-2031($MILLION)
  • FIGURE 39. BRAZIL CARRIER SCREENING MARKET,2021-2031($MILLION)
  • FIGURE 40. SAUDI ARABIA CARRIER SCREENING MARKET,2021-2031($MILLION)
  • FIGURE 41. SOUTH AFRICA CARRIER SCREENING MARKET,2021-2031($MILLION)
  • FIGURE 42. REST OF LAMEA CARRIER SCREENING MARKET,2021-2031($MILLION)
  • FIGURE 43. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 44. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 45. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 46. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 47. COMPETITIVE DASHBOARD
  • FIGURE 48. COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 49. TOP PLAYER POSITIONING, 2021
  • FIGURE 50. FULGENT GENETICS INC..: NET SALES ($MILLION)
  • FIGURE 51. ILLUMINA INC..: NET SALES ($MILLION)
  • FIGURE 52. DIASORIN S.P.A..: NET SALES ($MILLION)
  • FIGURE 53. NATERA INC..: NET SALES ($MILLION)
  • FIGURE 54. THERMO FISHER SCIENTIFIC INC..: NET SALES ($MILLION)
  • FIGURE 55. EUROFINS SCIENTIFIC.: NET SALES ($MILLION)
  • FIGURE 56. MYRIAD GENETICS, INC..: NET SALES ($MILLION)
  • FIGURE 57. OPKO HEALTH INC.: NET SALES ($MILLION)
  • FIGURE 58. QUEST DIAGNOSTICS INC..: NET SALES ($MILLION)
  • FIGURE 59. INVITAE CORPORATION.: NET SALES ($MILLION)